论文部分内容阅读
目的:探究米索前列醇联合缩宫素预防阴道分娩产后出血的临床效果和作用。方法:随机选取我院2012年阴道分娩的产妇162例,随机均分为实验组和对照组。对照组患者仅使用缩宫素注入臀部进行预防产后出血。对实验组患者在此基础上再注射米索前列醇至直肠内。观察记录两组患者的阴道出血情况。结果:两组患者的产后失血发生率、失血量均有很大差异,且比较结果有统计学意义。结论:米索前列醇联合缩宫素方法可以有效预防阴道分娩产后出血,适合在临床上推广施行。
Objective: To investigate the clinical effect and effect of misoprostol combined with oxytocin in preventing postpartum hemorrhage of vaginal delivery. Methods: Randomly selected 162 cases of vaginal delivery in our hospital in 2012, were randomly divided into experimental group and control group. Patients in the control group only used oxytocin to inject hips to prevent postpartum hemorrhage. On the basis of this, patients in the experimental group were injected with misoprostol into the rectum. Observe and record the vaginal bleeding of two groups of patients. Results: The incidence of postpartum hemorrhage and blood loss in both groups were very different, and the results were statistically significant. Conclusion: Misoprostol combined with oxytocin can effectively prevent vaginal delivery postpartum hemorrhage, suitable for clinical implementation.